Repligen (RGEN) Tops Q2 EPS by 5c, misses on revenue, provides guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $177.63 -0.31%
Revenue Growth %: +9.4%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +9.4%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.53, $0.05 better than the analyst estimate of $0.48. Revenue for the quarter came in at $159.2 million versus the consensus estimate of $165.93 million.
GUIDANCE:
Repligen sees FY2023 revenue of $635-665 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Barclays says AI trade is maturing, favors greater diversification
- Lumentum shares rise on analyst upgrades, AI demand outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
